Skip to main content
CDC Website

AIDS

HIV and Injection Drug Use Syringe Services Programs for HIV Prevention

This Vital Signs highlights the importance of expanding access to SSPs, which provide sterile needles and syringes and ideally offer many other comprehensive services to help improve the health of PWID and their communities, such as treatment for substance use disorder, HIV, and hepatitis testing and linkage to treatment, and safe disposal of used syringes.

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.

Webinar: ADAP Considerations for the 2024 Plan Year

This webinar provides a refresher for ADAPs on Open Enrollment, as well as relevant policy updates since the last Open Enrollment period, updates about the ongoing "unwinding" of Medicaid continuous coverage protections, and strategies for helping clients obtain and maintain coverage in the 2024 plan year and beyond.